DLNO/DLCO ratio evolution under targeted therapy in patients with pulmonary hypertension.
Respir Physiol Neurobiol
; 279: 103467, 2020 08.
Article
in En
| MEDLINE
| ID: mdl-32464180
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pulmonary Diffusing Capacity
/
Epoprostenol
/
Phosphodiesterase 5 Inhibitors
/
Endothelin Receptor Antagonists
/
Hypertension, Pulmonary
/
Antihypertensive Agents
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Respir Physiol Neurobiol
Year:
2020
Type:
Article